Physician profile
Michael Keevan Johnson
NPI 1356753321
$2,848.08
in general payments reported to CMS, 2019-2025
23 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $171 · 2021: $305 · 2022: $517 · 2023: $525 · 2024: $681 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,723.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $565.94 | 2020-2025 | Affinity, Simplimax |
| Convatec INC. | $446.61 | 2023-2024 | |
| Smith+Nephew, INC. | $395.28 | 2023-2025 | Bone Anchors With Arthroscopic Delivery System, Grafix Pl, Q-Fix |
| Novastep INC. | $280.20 | 2022 | |
| Stryker Corporation | $260.37 | 2019-2024 | Prostep Mica, Augment Injectable, N/A |
| Treace Medical Concepts, INC. | $111.92 | 2024 | |
| Integra Lifesciences Corporation | $101.47 | 2019-2021 | |
| Kerecis Limited | $98.19 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Paratek Pharmaceuticals, INC. | $74.32 | 2023-2025 | Nuzyra |
| Surgenex LLC | $73.03 | 2025 | Ardeograft, Renograft, Pellograft |
| Ani Pharmaceuticals, INC. | $64.40 | 2025 | Purified Cortrophin Gel |
| Zimmer Biomet Holdings, INC. | $59.58 | 2020 | |
| Depuy Synthes Sales INC. | $47.62 | 2022-2024 | Motoband |
| Kowa Pharmaceuticals America, INC. | $42.14 | 2023 | Seglentis |
| Abbvie INC. | $38.26 | 2022-2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $36.10 | 2025 | Acumed |
| Titan Surgical Group, LLC | $30.55 | 2023-2024 | |
| Deroyal Industries, INC. | $23.67 | 2024 | Flex Npwt Single Use System |
| Polynovo North America LLC | $22.81 | 2023 | |
| Medtronic, INC. | $22.22 | 2024 | Intellis Adaptivestim |
| Mimedx Group, INC. | $21.70 | 2024 | |
| Lifenet Health | $17.67 | 2025 | Theragenesis Wound Matrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.